top of page

Bionote USA Partners with PSIvet to Bring Affordable Diagnostic Analyzers and Biomarker Tests to Vet

5,000-Plus Veterinary Practices will have Access to Affordable Pricing on

Bionote USA In-Clinic Diagnostic Products as Part of Partnership

BIG LAKE, MINN. (July 25, 2022) — Bionote USA, manufacturer of quantitative, point-of-care veterinary analyzers and biomarker tests announces a new partnership with PSIvet, the nation's largest veterinary group purchasing organization. The partnership will make Bionote USA’s Vcheck line of analyzers and tests even more affordable to PSIvet’s 5,000-plus veterinary practices. The Vcheck V200 analyzer and tests can be used as a complement to a veterinary clinic’s point-of-care lab for time-saving diagnosis and faster initiation of treatment plans, along with significant cost savings per test.

Bionote USA was formed to bring diagnostic tools that fulfill best-in-care practice needs to the North American veterinary marketplace. This forward-focused, problem-solving approach to patient care resulted in the development of the Vcheck analyzer and its premium line of 13 quantitative diagnostic tests that eliminate the need for a reference lab by providing an actual numerical result - not positives, negatives or estimates. The Bionote approach allows veterinarians to prescribe better in-clinic care with quick quantitative measurement and reduced potential for sample degradation.

“We are pleased to partner with the largest veterinary buying cooperative in the U.S. and hope every PSIvet member will benefit from the Vcheck, the most affordable and accurate immunoassay analyzer

on the market,” said Randy Knick, president of Bionote USA. “The Vcheck provides fully quantitative results and is a complement and upgrade to every lab. We are truly excited to bring the Vcheck to every PSIvet member.”

As a leading group purchasing organization, PSIvet works with thousands of independent

veterinary practices to promote independence for the benefit of practice owners, pet parents

and pets. This partnership will allow autonomous veterinary practices to compete on the same level as larger organizations, with access to the same groundbreaking equipment, educational tools and certifications on a more affordable scale.

“We are excited about our new partnership with Bionote. This agreement will bring even more value to our members with a very reliable in-house diagnostic tool that can run many different tests accurately and affordably and help them provide great quality care for their patients in a timely manner,” Dan Jones, DVM, PSIvet’s executive director of business development.

Bionote USA’s line of quantitative diagnostic products are currently available in the U.S. To learn more about Bionote USA and the Vcheck line of analyzers and tests, visit For more about PSIvet, visit


bottom of page